miR-26a as a novel potential therapeutic via inhibit CD38 translation and may overcome datatumumab resistance in multiple myeloma(MM)

Jianjun Zhao; Yi Hu; Huimin Liu; Chuanfeng Fang; Chen Li; Fjorela Xhyliu; Juraj Bodo; Hayley Dysert; Gabriel Habermehl; Benjamin Russell; Wenjun Li; Marcia Chappell; Xiaofeng Jiang; Sarah Ondrejka; Eric Hsi; Jaroslaw P Maciejewski; Qing Yi; Kenneth C Anderson; Nikhil C Munshi; Geyou Ao; Jason Valent; Jianhong Lin

doi:10.4049/jimmunol.204.supp.91.10

miR-26a as a novel potential therapeutic via inhibit CD38 translation and may overcome datatumumab resistance in multiple myeloma(MM)

Jianjun Zhao
, Yi Hu
, Huimin Liu
, Chuanfeng Fang
, Chen Li
, Fjorela Xhyliu
, Juraj Bodo
, Hayley Dysert
, Gabriel Habermehl
, Benjamin Russell
, Wenjun Li
, Marcia Chappell
, Xiaofeng Jiang
, Sarah Ondrejka
, Eric Hsi
, Jaroslaw P Maciejewski
, Qing Yi
, Kenneth C Anderson
, Nikhil C Munshi
, Geyou Ao

Jason Valent, Jianhong Lin

Chemical and Biomedical Engineering

Research output: Contribution to journal › Article

Original language	English
Journal	The Journal of Immunology
Volume	204
Issue number	1_Supplement
DOIs	https://doi.org/10.4049/jimmunol.204.supp.91.10
State	Published - 2020

Access to Document

10.4049/jimmunol.204.supp.91.10

Cite this

Zhao, J., Hu, Y., Liu, H., Fang, C., Li, C., Xhyliu, F., Bodo, J., Dysert, H., Habermehl, G., Russell, B., Li, W., Chappell, M., Jiang, X., Ondrejka, S., Hsi, E., Maciejewski, J. P., Yi, Q., Anderson, K. C., Munshi, N. C., ... Lin, J. (2020). miR-26a as a novel potential therapeutic via inhibit CD38 translation and may overcome datatumumab resistance in multiple myeloma(MM). The Journal of Immunology, 204(1_Supplement). https://doi.org/10.4049/jimmunol.204.supp.91.10

@article{ad152e7323af498d8fad42a3fd4fd91b,

title = "miR-26a as a novel potential therapeutic via inhibit CD38 translation and may overcome datatumumab resistance in multiple myeloma(MM)",

author = "Jianjun Zhao and Yi Hu and Huimin Liu and Chuanfeng Fang and Chen Li and Fjorela Xhyliu and Juraj Bodo and Hayley Dysert and Gabriel Habermehl and Benjamin Russell and Wenjun Li and Marcia Chappell and Xiaofeng Jiang and Sarah Ondrejka and Eric Hsi and Maciejewski, \{Jaroslaw P\} and Qing Yi and Anderson, \{Kenneth C\} and Munshi, \{Nikhil C\} and Geyou Ao and Jason Valent and Jianhong Lin",

year = "2020",

doi = "10.4049/jimmunol.204.supp.91.10",

language = "English",

volume = "204",

journal = "The Journal of Immunology",

number = "1\_Supplement",

}

Zhao, J, Hu, Y, Liu, H, Fang, C, Li, C, Xhyliu, F, Bodo, J, Dysert, H, Habermehl, G, Russell, B, Li, W, Chappell, M, Jiang, X, Ondrejka, S, Hsi, E, Maciejewski, JP, Yi, Q, Anderson, KC, Munshi, NC, Ao, G, Valent, J & Lin, J 2020, 'miR-26a as a novel potential therapeutic via inhibit CD38 translation and may overcome datatumumab resistance in multiple myeloma(MM)', The Journal of Immunology, vol. 204, no. 1_Supplement. https://doi.org/10.4049/jimmunol.204.supp.91.10

TY - JOUR

T1 - miR-26a as a novel potential therapeutic via inhibit CD38 translation and may overcome datatumumab resistance in multiple myeloma(MM)

AU - Zhao, Jianjun

AU - Hu, Yi

AU - Liu, Huimin

AU - Fang, Chuanfeng

AU - Li, Chen

AU - Xhyliu, Fjorela

AU - Bodo, Juraj

AU - Dysert, Hayley

AU - Habermehl, Gabriel

AU - Russell, Benjamin

AU - Li, Wenjun

AU - Chappell, Marcia

AU - Jiang, Xiaofeng

AU - Ondrejka, Sarah

AU - Hsi, Eric

AU - Maciejewski, Jaroslaw P

AU - Yi, Qing

AU - Anderson, Kenneth C

AU - Munshi, Nikhil C

AU - Ao, Geyou

AU - Valent, Jason

AU - Lin, Jianhong

PY - 2020

Y1 - 2020

UR - http://dx.doi.org/10.4049/jimmunol.204.supp.91.10

U2 - 10.4049/jimmunol.204.supp.91.10

DO - 10.4049/jimmunol.204.supp.91.10

M3 - Article

VL - 204

JO - The Journal of Immunology

JF - The Journal of Immunology

IS - 1_Supplement

ER -

miR-26a as a novel potential therapeutic via inhibit CD38 translation and may overcome datatumumab resistance in multiple myeloma(MM)

Access to Document

Other files and links

Cite this